Ontology highlight
ABSTRACT:
OTHER RELATED OMICS DATASETS IN: MODEL1109130000MODEL1909260003MODEL1909260004MODEL1703310000MODEL1909260005MODEL1909260006MODEL1311110000MODEL1311110001
INSTRUMENT(S): Orbitrap Fusion ETD
ORGANISM(S): Streptococcus Pyogenes Stab901
TISSUE(S): B Cell
DISEASE(S): Disease Free
SUBMITTER: Wenzhang Chen
LAB HEAD: Wenzhang Chen
PROVIDER: PXD012466 | Pride | 2020-04-15
REPOSITORIES: Pride
Action | DRS | |||
---|---|---|---|---|
mapeixiang-DSSO-3.msf | Msf | |||
mapeixiang-DSSO-3.mzML | Mzml | |||
mapeixiang-DSSO-3.mzid.gz | Mzid | |||
mapeixiang-DSSO-3.pride.mgf.gz | Mgf | |||
mapeixiang-DSSO-3.raw | Raw |
Items per page: 1 - 5 of 11 |
Genome biology 20200226 1
<h4>Background</h4>CRISPR-Cas9 has been developed as a therapeutic agent for various infectious and genetic diseases. In many clinically relevant applications, constitutively active CRISPR-Cas9 is delivered into human cells without a temporal control system. Excessive and prolonged expression of CRISPR-Cas9 can lead to elevated off-target cleavage. The need for modulating CRISPR-Cas9 activity over time and dose has created the demand of developing CRISPR-Cas off switches. Protein and small molec ...[more]